Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib-Reference-Cited by-同舟云学术

Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib

Published:2014-03 Issue:4 Volume:88 Page:892-898
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gan Gregory N.,Weickhardt Andrew J.,Scheier Benjamin,Doebele Robert C.,Gaspar Laurie E.,Kavanagh Brian D.,Camidge D. Ross

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer;Kim;J Clin Oncol,2012

3. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

4. Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC);Riely;J Thorac Oncol,2012

5. Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer;Doebele;Clin Cancer Res,2012

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lokaltherapie im Stadium IV bei Oligopersistenz oder Progression;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

2. Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy;Clinical Lung Cancer;2024-08

3. Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials?;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer;Advances in Radiation Oncology;2024-07

5. ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies;Cancer Drug Resistance;2024-05-23